HealthEquity, Inc. (NASDAQ:HQY) Short Interest Up 19.5% in April

HealthEquity, Inc. (NASDAQ:HQY) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totaling 4,117,004 shares, an increase of 19.5% from the March 31st total of 3,446,029 shares. Approximately 4.9% of the company’s stock are sold short. Based on an average daily trading volume, of 1,019,262 shares, the days-to-cover ratio is currently 4.0 days.

HealthEquity Stock Performance

HQY traded up $0.37 during trading on Friday, hitting $82.40. The stock had a trading volume of 794,974 shares, compared to its average volume of 954,910. The company has a 50 day moving average price of $80.91 and a 200-day moving average price of $88.04. The firm has a market cap of $6.96 billion, a price-to-earnings ratio of 33.50, a P/E/G ratio of 1.49 and a beta of 0.19. HealthEquity has a one year low of $72.76 and a one year high of $116.65. The company has a debt-to-equity ratio of 0.45, a current ratio of 3.27 and a quick ratio of 3.27.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, March 17th. The company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.05. The firm had revenue of $334.59 million during the quarter, compared to analysts’ expectations of $332.48 million. HealthEquity had a return on equity of 13.86% and a net margin of 16.39%.HealthEquity’s quarterly revenue was up 7.3% compared to the same quarter last year. As a group, research analysts predict that HealthEquity will post 3.84 EPS for the current year.

Wall Street Analyst Weigh In

HQY has been the topic of a number of recent research reports. Raymond James Financial set a $100.00 target price on HealthEquity in a research report on Tuesday, February 17th. UBS Group set a $110.00 price target on HealthEquity in a research note on Tuesday, February 17th. JPMorgan Chase & Co. reduced their target price on HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a research note on Wednesday, March 18th. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a research note on Thursday, January 22nd. Finally, Jefferies Financial Group set a $108.00 price target on HealthEquity in a research note on Thursday, February 19th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, HealthEquity currently has an average rating of “Moderate Buy” and a consensus price target of $111.79.

Hedge Funds Weigh In On HealthEquity

Several hedge funds and other institutional investors have recently added to or reduced their stakes in HQY. Acumen Wealth Advisors LLC acquired a new position in HealthEquity in the 4th quarter valued at $27,000. Caitong International Asset Management Co. Ltd raised its holdings in shares of HealthEquity by 1,723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after buying an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd acquired a new position in shares of HealthEquity during the 4th quarter worth $28,000. True Wealth Design LLC raised its holdings in shares of HealthEquity by 3,522.2% during the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock worth $31,000 after buying an additional 317 shares in the last quarter. Finally, Leonteq Securities AG raised its holdings in shares of HealthEquity by 159.9% during the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after buying an additional 235 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.